Wednesday, February 08, 2006


Viral Hepatitis C - Viral Hepatitis and HIV Coinfection


Viral Hepatitis and HIV Coinfection
Medscape News - In Western countries, chronic HBV infection affects 5% to 10% of HIV-positive individuals. However, a larger proportion of the HIV-infected population has been exposed to HBV in the past. Isolated hepatitis B core antibody (anti-HBc) is more common

Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in Acceleration
RxPG - "The initial success of our efforts to accelerate the HCV clinical trial program for Tarvacin Anti-Viral is gratifying in view of Tarvacin's promise as an important new treatment option for a number of viral infections, including chronic hepatitis C

Novartis and Idenix seek European approval of telbivudine (LDT600) for
WebWire - * Telbivudine represents a potential new standard of care for hepatitis B treatment through rapid and sustained viral suppression * US and European submissions now completed, submissions in key Asian markets planned to be completed in the first